These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36205826)
21. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study. Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373 [TBL] [Abstract][Full Text] [Related]
22. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Kantarjian HM; Shtalrid M; Kurzrock R; Blick M; Dalton WT; LeMaistre A; Stass SA; McCredie KB; Gutterman J; Freireich EJ Am J Med; 1988 Nov; 85(5):639-44. PubMed ID: 3189367 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of monocytosis in patients with myeloproliferative disorders. Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764 [TBL] [Abstract][Full Text] [Related]
24. Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia. Khan M; Muzzafar T; Kantarjian H; Badar I; Short N; Wang X; Chamoun K; Jain P; DiNardo C; Pemmaraju N; Bose P; Borthakur G; Cortes J; Verstovsek S; Garcia-Manero G; Estrov Z Ann Hematol; 2018 Jul; 97(7):1183-1191. PubMed ID: 29557496 [TBL] [Abstract][Full Text] [Related]
25. Leukemic pneumonitis as a poor prognostic factor in chronic myelomonocytic leukemia. Yamauchi K; Omata T Respiration; 1992; 59(2):119-21. PubMed ID: 1620981 [TBL] [Abstract][Full Text] [Related]
26. Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML. Patnaik MM; Vallapureddy R; Yalniz FF; Hanson CA; Ketterling RP; Lasho TL; Finke C; Al-Kali A; Gangat N; Tefferi A Am J Hematol; 2018 Jan; 93(1):65-73. PubMed ID: 29023992 [TBL] [Abstract][Full Text] [Related]
27. Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system. Diamantopoulos PT; Kotsianidis I; Symeonidis A; Pappa V; Galanopoulos A; Gogos D; Karakatsanis S; Papadaki H; Palla A; Hatzimichael E; Dimou M; Papageorgiou S; Delimpasis S; Papaioannou M; Papoutselis M; Kourakli A; Tsokanas D; Anagnostopoulos A; Kontos CK; Panayiotidis P; Viniou NA; Leuk Lymphoma; 2019 Jul; 60(7):1721-1730. PubMed ID: 30424699 [TBL] [Abstract][Full Text] [Related]
28. DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia. Patnaik MM; Barraco D; Lasho TL; Finke CM; Hanson CA; Ketterling RP; Gangat N; Tefferi A Am J Hematol; 2017 Jan; 92(1):56-61. PubMed ID: 27733013 [TBL] [Abstract][Full Text] [Related]
29. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia]. Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642 [TBL] [Abstract][Full Text] [Related]
30. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia. Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178 [TBL] [Abstract][Full Text] [Related]
31. Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations. Gur HD; Loghavi S; Garcia-Manero G; Routbort M; Kanagal-Shamanna R; Quesada A; Khogeer H; Pierce S; Medeiros LJ; Kantarjian H; Khoury JD Am J Surg Pathol; 2018 Jun; 42(6):799-806. PubMed ID: 29596070 [TBL] [Abstract][Full Text] [Related]
32. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group. Wattel E; Guerci A; Hecquet B; Economopoulos T; Copplestone A; Mahé B; Couteaux ME; Resegotti L; Voglova V; Foussard C; Pegourié B; Michaux JL; Deconinck E; Stoppa AM; Mufti G; Oscier D; Fenaux P Blood; 1996 Oct; 88(7):2480-7. PubMed ID: 8839839 [TBL] [Abstract][Full Text] [Related]